Literature DB >> 34780275

Nontypeable Haemophilus influenzae Infection Impedes Pseudomonas aeruginosa Colonization and Persistence in Mouse Respiratory Tract.

Natalie R Lindgren1,2, Lea Novak3, Benjamin C Hunt1,2, Melissa S McDaniel1,2, W Edward Swords1,2.   

Abstract

Patients with cystic fibrosis (CF) experience lifelong respiratory infections, which are a significant cause of morbidity and death. These infections are polymicrobial in nature, and the predominant bacterial species undergo a predictable series of changes as patients age. Young patients have populations dominated by opportunists that are typically found within the microbiome of the human nasopharynx, such as nontypeable Haemophilus influenzae (NTHi); these are eventually supplanted, and the population within the CF lung is later dominated by pathogens such as Pseudomonas aeruginosa. In this study, we investigated how initial colonization with NTHi impacts colonization and persistence of P. aeruginosa in the respiratory tract. Analysis of polymicrobial biofilms in vitro by confocal microscopy revealed that NTHi promoted greater P. aeruginosa biofilm volume and diffusion. However, sequential respiratory infection of mice with NTHi followed by P. aeruginosa resulted in significantly lower levels of P. aeruginosa, compared to infection with P. aeruginosa alone. Coinfected mice also had reduced airway tissue damage and lower levels of inflammatory cytokines, compared with P. aeruginosa-infected mice. Similar results were observed after instillation of heat-inactivated NTHi bacteria or purified NTHi lipooligosaccharide endotoxin prior to P. aeruginosa introduction. Based on these results, we conclude that NTHi significantly reduces susceptibility to subsequent P. aeruginosa infection, most likely due to priming of host innate immunity rather than a direct competitive interaction between species. These findings have potential significance with regard to therapeutic management of early-life infections in patients with CF.

Entities:  

Keywords:  Haemophilus influenzae; Pseudomonas aeruginosa; bacteria; biofilm; cystic fibrosis; lung infection

Mesh:

Year:  2021        PMID: 34780275      PMCID: PMC8853672          DOI: 10.1128/IAI.00568-21

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  55 in total

Review 1.  Pathogenesis of early lung disease in cystic fibrosis: a window of opportunity to eradicate bacteria.

Authors:  Timothy D Starner; Paul B McCray
Journal:  Ann Intern Med       Date:  2005-12-06       Impact factor: 25.391

Review 2.  The airway microbiome in cystic fibrosis and implications for treatment.

Authors:  Edith T Zemanick; Scott D Sagel; Jonathan K Harris
Journal:  Curr Opin Pediatr       Date:  2011-06       Impact factor: 2.856

3.  Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces.

Authors:  Adam J Ratner; Elena S Lysenko; Marina N Paul; Jeffrey N Weiser
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

Review 4.  Clinical manifestations and treatment of pulmonary infections in cystic fibrosis.

Authors:  J L Burns; B W Ramsey; A L Smith
Journal:  Adv Pediatr Infect Dis       Date:  1993

Review 5.  Pseudomonas aeruginosa: new insights into pathogenesis and host defenses.

Authors:  Shaan L Gellatly; Robert E W Hancock
Journal:  Pathog Dis       Date:  2013-03-15       Impact factor: 3.166

6.  Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.

Authors:  J L Burns; R L Gibson; S McNamara; D Yim; J Emerson; M Rosenfeld; P Hiatt; K McCoy; R Castile; A L Smith; B W Ramsey
Journal:  J Infect Dis       Date:  2000-12-27       Impact factor: 5.226

Review 7.  Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis.

Authors:  Elio Rossi; Ruggero La Rosa; Jennifer A Bartell; Rasmus L Marvig; Janus A J Haagensen; Lea M Sommer; Søren Molin; Helle Krogh Johansen
Journal:  Nat Rev Microbiol       Date:  2020-11-19       Impact factor: 60.633

8.  Lung epithelial cells are essential effectors of inducible resistance to pneumonia.

Authors:  J O Cleaver; D You; D R Michaud; F A Guzmán Pruneda; M M Leiva Juarez; J Zhang; P M Weill; R Adachi; L Gong; S J Moghaddam; M E Poynter; M J Tuvim; S E Evans
Journal:  Mucosal Immunol       Date:  2013-05-01       Impact factor: 7.313

Review 9.  The Lung Microbiome: New Principles for Respiratory Bacteriology in Health and Disease.

Authors:  Robert P Dickson; Gary B Huffnagle
Journal:  PLoS Pathog       Date:  2015-07-09       Impact factor: 6.823

10.  The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention.

Authors:  Thomas H Hampton; Deanna M Green; Garry R Cutting; Hilary G Morrison; Mitchell L Sogin; Alex H Gifford; Bruce A Stanton; George A O'Toole
Journal:  Microbiome       Date:  2014-04-28       Impact factor: 14.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.